Optimizing the use of CROs by academia and small companies

Nat Rev Drug Discov. 2013 Jul;12(7):487-8. doi: 10.1038/nrd4057.

Authors

Rachel F Lane¹, Lauren G Friedman, Curtis Keith, Steven P Braithwaite, Julie A Frearson, David A Lowe, Frank M Longo, Lorenzo M Refolo, D Martin Watterson, Katya Tsaioun, Diana W Shineman, Howard M Fillit

Affiliation

¹ Alzheimer's Drug Discovery Foundation, 57 W. 57th Street, New York, New York 10019, USA.

PMID: 23812255
DOI: 10.1038/nrd4057

No abstract available

MeSH terms

Academies and Institutes / economics
Academies and Institutes / organization & administration*
Academies and Institutes / standards
Capacity Building / organization & administration
Capacity Building / standards
Contract Services / economics
Contract Services / methods
Contract Services / organization & administration*
Contract Services / standards
Drug Discovery / economics
Drug Discovery / methods*
Drug Discovery / organization & administration
Interdisciplinary Communication
Technology, Pharmaceutical / economics
Technology, Pharmaceutical / methods
Technology, Pharmaceutical / organization & administration*